Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/protection-from-diabetes-induced-atherosclerosis-and-renal-disease-by-3Z4DshQvID
References (38)
-
H. Gerstein, Michael Miller, R. Byington, D. Goff, J. Bigger, J. Buse, W. Cushman, S. Genuth, F. Ismail-Beigi, R. Grimm, J. Probstfield, D. Simons-Morton, W. Friedewald (2008)
Effects of intensive glucose lowering in type 2 diabetes.The New England journal of medicine, 358 24
-
H. Fujita, H. Fujishima, S. Chida, Keiko Takahashi, Z. Qi, Y. Kanetsuna, M. Breyer, Raymond Harris, Yuichiro Yamada, Takamune Takahashi (2009)
Reduction of renal superoxide dismutase in progressive diabetic nephropathy.Journal of the American Society of Nephrology : JASN, 20 6
-
D. Nathan, P. Cleary, J. Backlund, S. Genuth, J. Lachin, T. Orchard, P. Raskin, B. Zinman (2005)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.The New England journal of medicine, 353 25
-
S. Nissen, S. Nicholls, I. Sipahi, P. Libby, J. Raichlen, C. Ballantyne, J. Davignon, R. Erbel, J. Tardif, P. Schoenhagen, T. Crowe (2006)
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.JAMA, 295 13
-
N. Hanssen, K. Wouters, M. Huijberts, M. Gijbels, J. Sluimer, J. Scheijen, S. Heeneman, E. Biessen, M. Daemen, M. Brownlee, D. Kleijn, C. Stehouwer, G. Pasterkamp, C. Schalkwijk (2014)
Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype.European heart journal, 35 17
-
J. Nunnelee (2008)
Review of an article: The ADVANCE Collaborative Group. (2008). Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. NEJM 2008;358:2560-2572.Journal of Vascular Nursing, 26
-
S. Prato (2009)
Megatrials in type 2 diabetes. From excitement to frustration?Diabetologia, 52
-
P. Fioretto, M. Steffes, D. Sutherland, F. Goetz, M. Mauer (1998)
Reversal of lesions of diabetic nephropathy after pancreas transplantation.The New England journal of medicine, 339 2
-
Anushka Patel, S. MacMahon, J. Chalmers, B. Neal, L. Billot, M. Woodward, M. Marre, M. Cooper, P. Glasziou, D. Grobbee, P. Hamet, S. Harrap, S. Heller, Li-sheng Liu, G. Mancia, C. Mogensen, C. Pan, N. Poulter, A. Rodgers, B. Williams, Severine Bompoint, B. Galan, R. Joshi, F. Travert (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.The New England journal of medicine, 358 24
-
R. Holman, S. Paul, M. Bethel, D. Matthews, H. Andrew, W. Neil (2008)
10-year follow-up of intensive glucose control in type 2 diabetes.The New England journal of medicine, 359 15
-
E. Ellis (2007)
Reactive carbonyls and oxidative stress: potential for therapeutic intervention.Pharmacology & therapeutics, 115 1
-
N. Ahmed (2005)
Advanced glycation endproducts--role in pathology of diabetic complications.Diabetes research and clinical practice, 67 1
-
(1998)
Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet, 352
-
S. Menini, C. Iacobini, C. Ricci, A. Scipioni, Claudia Fantauzzi, A. Giaccari, E. Salomone, R. Canevotti, A. Lapolla, M. Orioli, G. Aldini, G. Pugliese (2012)
D‐carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammationBritish Journal of Pharmacology, 166
-
Stéphanie Velez, N. Nair, V. Reddy (2008)
Transition metal ion binding studies of carnosine and histidine: biologically relevant antioxidants.Colloids and surfaces. B, Biointerfaces, 66 2
-
Diabetes Control, D. Nathan, S. Genuth, J. Lachin, P. Cleary, O. Crofford, M. Davis, L. Rand, C. Siebert (1993)
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.The New England journal of medicine, 329 14
-
Andrew Li, K. Brown, M. Silvestre, T. Willson, W. Palinski, C. Glass (2000)
Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient miceJournal of Clinical Investigation, 106
-
M. Shichiri, H. Kishikawa, Yasuo Ohkubo, N. Wake (2000)
Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.Diabetes care, 23 Suppl 2
-
S. Menini, C. Iacobini, C. Ricci, G. Oddi, C. Pesce, Francesco Pugliese, K. Block, Hanna Abboud, Marco Giorgio, E. Migliaccio, PierGiuseppe Pelicci, Giuseppe Pugliese (2007)
Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulationDiabetologia, 50
-
L. Bharadwaj, G. Davies, I. Xavier, N. Ovsenek (2002)
l-carnosine and verapamil inhibit hypoxia-induced expression of hypoxia inducible factor (HIF-1 alpha) in H9c2 cardiomyoblasts.Pharmacological research, 45 3
-
A. Nègre-Salvayre, Christelle Coatrieux, C. Ingueneau, R. Salvayre (2008)
Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitorsBritish Journal of Pharmacology, 153
-
L. Brånén, L. Pettersson, M. Lindholm, S. Zaina (2001)
A Procedure for Obtaining Whole Mount Mouse Aortas that Allows Atherosclerotic Lesions to be QuantifiedThe Histochemical Journal, 33
-
Masakazu Haneda, Daisuke Koya, M. Isono, R. Kikkawa (2003)
Overview of glucose signaling in mesangial cells in diabetic nephropathy.Journal of the American Society of Nephrology : JASN, 14 5
-
J. Chalmers, M. Cooper (2008)
UKPDS and the legacy effect.The New England journal of medicine, 359 15
-
C. Iacobini, S. Menini, C. Ricci, A. Scipioni, V. Sansoni, S. Cordone, M. Taurino, M. Serino, G. Marano, M. Federici, F. Pricci, G. Pugliese (2009)
Accelerated Lipid-Induced Atherogenesis in Galectin-3–Deficient Mice: Role of Lipoxidation via Receptor-Mediated MechanismsArteriosclerosis, Thrombosis, and Vascular Biology, 29
-
E. Decker, S. Livisay, S. Zhou (2000)
A re-evaluation of the antioxidant activity of purified carnosine.Biochemistry. Biokhimiia, 65 7
-
W. Duckworth, C. Abraira, Thomas Moritz, D. Reda, N. Emanuele, P. Reaven, F. Zieve, J. Marks, S. Davis, R. Hayward, S. Warren, S. Goldman, M. Mccarren, Mary Vitek, W. Henderson, Grant Huang (2009)
Glucose control and vascular complications in veterans with type 2 diabetes.The New England journal of medicine, 360 2
-
G. Basta, A. Schmidt, R. Caterina (2004)
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.Cardiovascular research, 63 4
-
S. Goh, M. Cooper (2008)
The role of advanced glycation end products in progression and complications of diabetesThe Journal of Clinical Endocrinology and Metabolism, 93
-
G. Vistoli, M. Orioli, A. Pedretti, L. Regazzoni, R. Canevotti, Gianpaolo Negrisoli, M. Carini, G. Aldini (2009)
Design, Synthesis, and Evaluation of Carnosine Derivatives as Selective and Efficient Sequestering Agents of Cytotoxic Reactive Carbonyl SpeciesChemMedChem, 4
-
T. Bondeva, J. Heinzig, C. Ruhe, G. Wolf (2013)
Advanced glycated end-products affect HIF-transcriptional activity in renal cells.Molecular endocrinology, 27 11
-
G. Aldini, M. Orioli, G. Rossoni, Federica Savi, P. Braidotti, G. Vistoli, K. Yeum, Gianpaolo Negrisoli, M. Carini (2010)
The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese ratsJournal of Cellular and Molecular Medicine, 15
-
C. Iacobini, S. Menini, G. Oddi, C. Ricci, L. Amadio, F. Pricci, A. Olivieri, M. Sorcini, U. Mario, C. Pesce, G. Pugliese (2004)
Galectin‐3/AGE‐receptor 3 knockout mice show accelerated AGE‐induced glomerular injury: evidence for a protective role of galectin‐3 as an AGE receptorThe FASEB Journal, 18
-
G. Aldini, R. Facino, G. Beretta, M. Carini (2005)
Carnosine and related dipeptides as quenchers of reactive carbonyl species: From structural studies to therapeutic perspectivesBioFactors, 24
-
H. Lander, J. Tauras, J. Ogiste, O. Hori, R. Moss, A. Schmidt (1997)
Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress*The Journal of Biological Chemistry, 272
-
R. Turner, C. Fox, Matthews, H. Mcelroy, C. Cull, R. Holman, P. Neil, D. Hadden, D. Wright, É. Manley, I. Stratton, Uk Diabetes, E. Kohner, Frighi, Michael Gnant (1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.The Lancet
-
S. Gordon, L. Lawson, S. Rabinowitz, P. Crocker, L. Morris, V. Perry (1992)
Antigen markers of macrophage differentiation in murine tissues.Current topics in microbiology and immunology, 181
-
S. Tan, Arpeeta Sharma, N. Stefanovic, D. Yuen, T. Karagiannis, C. Meyer, K. Ward, M. Cooper, J. Haan (2014)
Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney DiseaseDiabetes, 63
- Publisher
- Springer Journals
- Copyright
- Copyright © 2015 by Springer-Verlag Berlin Heidelberg
- Subject
- Medicine & Public Health; Internal Medicine; Metabolic Diseases; Human Physiology
- ISSN
- 0012-186X
- eISSN
- 1432-0428
- DOI
- 10.1007/s00125-014-3467-6
- pmid
- 25471794
- Publisher site
- See Article on Publisher Site
Abstract
These data show that DCO protects mice from diabetes-induced vascular and renal disease and that protection against atherosclerosis is more effectively achieved by early treatment than by late treatment, thus suggesting that early inhibition of AGE formation attenuates progression of macroangiopathy and favours development of more stable lesions.
Journal
Diabetologia – Springer Journals
Published: Apr 1, 2015